Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan,
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Serum protein electrophoresis in both patients. Case 1 shows a 34 g/L... | Download Scientific Diagram
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Plasma cell myeloma expressing IgG heavy chain with co-expression of... | Download Scientific Diagram
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Abstract
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms
Episode 040: Myeloma Series, Pt.1 - Intro to Testing and MGUS — The Fellow On Call
Case 966-- Clinical Chemistry Case
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Living With - HealthTree for Multiple Myeloma
Multiple myeloma: what a non-haematologist should know | RCP Journals